Literature DB >> 33663583

Geographical accessibility of medicines: a systematic literature review of pharmacy mapping.

Cindrel Tharumia Jagadeesan1, Veronika J Wirtz2.   

Abstract

BACKGROUND: Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims to provide a systematic review of literature on the accessibility of medicines by studying the geographical distribution of pharmacies using Spatial Analytical methods.
METHODS: As systematic review of scientific peer-reviewed literature between 2000 and 2018 was carried out using PubMed, Web of Science, Google Scholar, Google and the Preferred Reporting items for Systematic Reviews and Meta-Analyses (PRISMA). Data regarding pharmacy density, distance to pharmacies in relation of pharmacy to sociodemographic factors and pharmacy characteristics were extracted from studies that meet the inclusion criteria.
FINDINGS: Twenty papers fulfilled our inclusion criteria, of which only three were from middle income countries and rest from high-income economies. Pharmacy density per population was reported in 15 studies. Although geographical information was utilized in all studies, only 14 studies reported distance to pharmacies represented as Euclidean (straight line) distance. Disparities in accessibility was reported according to population income and rural or urban location. Seven studies described additional pharmacy characteristics including opening hours, presence of a pharmacist and delivery services.
CONCLUSIONS: Geographical accessibility is a key dimension of access to medicines. Pharmacy density per population is a relevant indicator to assess geographical accessibility which should be complemented by an equity analysis using socio-demographic information and population perception of accessibility.

Entities:  

Keywords:  Accessibility; Medicines; Pharmaceutical; Spatial analysis

Year:  2021        PMID: 33663583      PMCID: PMC7931596          DOI: 10.1186/s40545-020-00291-7

Source DB:  PubMed          Journal:  J Pharm Policy Pract        ISSN: 2052-3211


  22 in total

1.  Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities.

Authors:  Dima Mazen Qato; Jocelyn Wilder; Shannon Zenk; Andrew Davis; Jennifer Makelarski; Stacy Tessler Lindau
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-30

2.  A cross-sectional survey of the access of older people in the Scottish Highlands to general medical practices, community pharmacies and prescription medicines.

Authors:  Gordon F Rushworth; Scott Cunningham; Sharon Pfleger; Jenny Hall; Derek Stewart
Journal:  Res Social Adm Pharm       Date:  2017-01-25

3.  Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme.

Authors:  Kim Ward; David Sanders; Henry Leng; Allyson M Pollock
Journal:  Bull World Health Organ       Date:  2014-05-09       Impact factor: 9.408

4.  Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services.

Authors:  Marie A Chisholm-Burns; Christina A Spivey; Justin Gatwood; Adam Wiss; Kenneth Hohmeier; Steven R Erickson
Journal:  Am J Health Syst Pharm       Date:  2017-04-04       Impact factor: 2.637

Review 5.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

6.  Monitoring inequality: an emerging priority for health post-2015.

Authors:  Ahmad Reza Hosseinpoor; Nicole Bergen; Veronica Magar
Journal:  Bull World Health Organ       Date:  2015-09-01       Impact factor: 9.408

7.  Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation.

Authors:  Adam Todd; Alison Copeland; Andy Husband; Adetayo Kasim; Clare Bambra
Journal:  BMJ Open       Date:  2015-05-08       Impact factor: 2.692

8.  The availability of pharmacies in the United States: 2007-2015.

Authors:  Dima Mazen Qato; Shannon Zenk; Jocelyn Wilder; Rachel Harrington; Darrell Gaskin; G Caleb Alexander
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

9.  Cutting care clusters: the creation of an inverse pharmacy care law? An area-level analysis exploring the clustering of community pharmacies in England.

Authors:  Adam Todd; Katie Thomson; Adetayo Kasim; Clare Bambra
Journal:  BMJ Open       Date:  2018-08-01       Impact factor: 2.692

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  1 in total

1.  Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic.

Authors:  Rodrigo Murteira; Sónia Romano; Inês Teixeira; Carolina Bulhosa; Sérgio Sousa; Maria Inês Conceição; Anabela Fonseca-Silva; Humberto Martins; António Teixeira Rodrigues
Journal:  Value Health       Date:  2022-04-12       Impact factor: 5.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.